TY - JOUR
T1 - Externally validated digital decision support tool for time-to-osteoradionecrosis risk-stratification using right-censored multi-institutional observational cohorts
AU - Humbert-Vidan, Laia
AU - Kamel, Serageldin
AU - Wentzel, Andrew
AU - Kaffey, Zaphanlene
AU - Abdelaal, Moamen
AU - Spier, Kyle B.
AU - West, Natalie A.
AU - Marai, G. Elisabeta
AU - Canahuate, Guadalupe
AU - Zhang, Xinhua
AU - Chen, Melissa M.
AU - Wahid, Kareem A.
AU - Rigert, Jillian
AU - Hosseinian, Seyedmohammadhossein
AU - Schaefer, Andrew J.
AU - Brock, Kristy K.
AU - Chambers, Mark
AU - Otun, Adegbenga O.
AU - Aponte-Wesson, Ruth
AU - Patel, Vinod
AU - Hope, Andrew
AU - Phan, Jack
AU - Garden, Adam S.
AU - Frank, Steven J.
AU - Morrison, William H.
AU - Spiotto, Michael T.
AU - Rosenthal, David
AU - Lee, Anna
AU - He, Renjie
AU - Naser, Mohamed A.
AU - Watson, Erin
AU - Hutcheson, Katherine A.
AU - Mohamed, Abdallah S.R.
AU - Sandulache, Vlad C.
AU - van Dijk, Lisanne V.
AU - Moreno, Amy C.
AU - Urbano, Teresa Guerrero
AU - Fuller, Clifton D.
AU - Lai, Stephen Y.
N1 - Publisher Copyright:
© 2025
PY - 2025/6
Y1 - 2025/6
N2 - Background: Existing studies on osteoradionecrosis of the jaw (ORNJ) have primarily used cross-sectional data, assessing risk factors at a single time point. Determining the time-to-event profile of ORNJ has important implications to monitor oral health in head and neck cancer (HNC) long-term survivors. Methods: Data were retrospectively obtained for a clinical observational cohort of 1129 patients (198 ORNJ cases) with HNC treated with radiotherapy (RT) at The University of Texas MD Anderson Cancer Center. A Weibull Accelerated Failure Time model was trained on previously identified dosimetric, clinical and demographic predictors. External validation was performed using an independent cohort of 265 patients (92 ORNJ cases) treated at Guy's and St. Thomas’ Hospitals. To facilitate clinical implementation of the model, an online graphical user interface (GUI) was developed, including formal stakeholder usability testing. Results: Our model identified that gender (males), pre-RT dental extractions and D25% were associated with a 38 %, 27 % and 12 % faster onset of ORNJ, respectively, with adjusted time ratios of 0.62 (p = 0.11), 0.73 (p = 0.13) and 0.88 (p < 0.005). The model demonstrated strong internal calibration (integrated Brier score of 0.133, D-calibration p-value 0.998) and optimal discrimination at 72 months (Harrell's C-index of 0.72). Conclusion: This study is the first to demonstrate a direct relationship between radiation dose and the time to ORNJ onset, providing a novel characterization of the impact of delivered dose and patient-related factors not only on the probability of a late effect (ORNJ), but the conditional risk during survivorship.
AB - Background: Existing studies on osteoradionecrosis of the jaw (ORNJ) have primarily used cross-sectional data, assessing risk factors at a single time point. Determining the time-to-event profile of ORNJ has important implications to monitor oral health in head and neck cancer (HNC) long-term survivors. Methods: Data were retrospectively obtained for a clinical observational cohort of 1129 patients (198 ORNJ cases) with HNC treated with radiotherapy (RT) at The University of Texas MD Anderson Cancer Center. A Weibull Accelerated Failure Time model was trained on previously identified dosimetric, clinical and demographic predictors. External validation was performed using an independent cohort of 265 patients (92 ORNJ cases) treated at Guy's and St. Thomas’ Hospitals. To facilitate clinical implementation of the model, an online graphical user interface (GUI) was developed, including formal stakeholder usability testing. Results: Our model identified that gender (males), pre-RT dental extractions and D25% were associated with a 38 %, 27 % and 12 % faster onset of ORNJ, respectively, with adjusted time ratios of 0.62 (p = 0.11), 0.73 (p = 0.13) and 0.88 (p < 0.005). The model demonstrated strong internal calibration (integrated Brier score of 0.133, D-calibration p-value 0.998) and optimal discrimination at 72 months (Harrell's C-index of 0.72). Conclusion: This study is the first to demonstrate a direct relationship between radiation dose and the time to ORNJ onset, providing a novel characterization of the impact of delivered dose and patient-related factors not only on the probability of a late effect (ORNJ), but the conditional risk during survivorship.
KW - Decision support tool
KW - Head and neck cancers
KW - Normal tissue complication prediction
KW - Osteoradionecrosis of the jaw
KW - Radiation-induced toxicity
KW - Radiotherapy
KW - Time-to-event prediction models
UR - http://www.scopus.com/inward/record.url?scp=105003081767&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105003081767&partnerID=8YFLogxK
U2 - 10.1016/j.radonc.2025.110890
DO - 10.1016/j.radonc.2025.110890
M3 - Article
C2 - 40222595
AN - SCOPUS:105003081767
SN - 0167-8140
VL - 207
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
M1 - 110890
ER -